Anti-GAD autoimmune encephalitis
Evidence-based neurology checklist on anti-gad autoimmune encephalitis: Demographic features This usually affects young and middle-aged women Clinical features Associated features Cerebrospinal fluid (CSF) analysis Magnetic resonance imaging (MRI) brain Other investigations Treatment Acronym
Demographic features
- This usually affects young and middle-aged women
Clinical features
Associated features
Cerebrospinal fluid (CSF) analysis
Magnetic resonance imaging (MRI) brain
Other investigations
Treatment
Acronym
References
- Zhu F, Shan W, Lv R, Li Z, Wang Q. Clinical characteristics of GAD 65-associated autoimmune encephalitis. Acta Neurol Scand 2020; 142:281-293.
- Zhang YF, Yu N, Lin XJ, et al. Clinical characteristics and outcomes of autoimmune encephalitis patients associated with anti-glutamate decarboxylase antibody 65. Clin Neurol Neurosurg 2020; 196:106082.
- Sharma CM, Pandey RK, Kumawat BL, Khandelwal D, Gandhi P. A unique combination of autoimmune limbic encephalitis, type 1 diabetes, and Stiff person syndrome associated with GAD-65 antibody. Ann Indian Acad Neurol 2016; 19:146-149.
- Mirabelli-Badenier M, Morana G, Pinto F, et al. Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia. Arch Neurol 2012; 69:1064-1066.
- AlAbdulghafoor F, Behbehani R, Johar A, Alroughani R. Antiglutamate acid decarboxylase seropositive brain stem encephalitis. BMJ Case Rep 2023; 16:e254026.
- And 8 more. Subscribe to see the full list
